Welcome to LookChem.com Sign In|Join Free
  • or
Pyrrolidine, 1-(4,4-dimethyl-1-cyclohexen-1-yl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

41172-02-5

Post Buying Request

41172-02-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

41172-02-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 41172-02-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,1,7 and 2 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 41172-02:
(7*4)+(6*1)+(5*1)+(4*7)+(3*2)+(2*0)+(1*2)=75
75 % 10 = 5
So 41172-02-5 is a valid CAS Registry Number.

41172-02-5Relevant academic research and scientific papers

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

-

Page/Page column 71, (2011/10/13)

The invention provides novel spirotetrahydronaphthalene compounds of Formula α that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

AMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1

-

Page 93-94, (2010/02/07)

Compounds of the formula (I) provide pharmacological agents which lower intracellular glucocorticoid concentrations in mammals, in particular, intracellular cortisol levels in humans. Therefore, the compounds of the instant invention improve insulin sensitivity in the muscle and the adipose tissue, and reduce lipolysis and free fatty acid production in the adipose tissue. The compounds of the invention lower hepatic glucocorticoid concentration in mammals, in particular, hepatic cortisol concentration in humans, resulting in inhibition of hepatic gluconeogenesis and lowering of plasma glucose levels. Thus, the compounds of the instant invention may be particularly useful in mammals as hypoglycemic agents for the treatment and prevention of conditions in which hyperglycemia and/or insulin resistance are implicated, such as type-2 diabetes. The compounds of the invention may also be used to treat other glucocorticoid associated disorders, such as Syndrome-X, dyslipidemia, hypertension and central obesity. The invention furthermore relates to the use of the compounds according to the invention for the preparation of medicaments, in particular of medicaments useful for the treatment and prevention of glucocorticoid associated disorders, by improving insulin sensitivity, reducing plasma glucose levels, reducing lipolysis and free fatty acid production, and by decreasing visceral adipose tissue formation.

A useful α, α' - Annulation reaction of enamines

Frontier, Alison J.,Danishefsky, Samuel J.,Koppel, Gary A.,Meng, Dongfang

, p. 12721 - 12736 (2007/10/03)

The reactions of a series of enamines generated from a range of cyclic ketones with chloromethyl and iodomethyl vinyl ketone have been studied. The principal products are bridged ring diketones. The four carbon bridge, bearing a 2-oxobutyl function, spans

Photochemistry of 6-trifluoromethyl-4,4-dimethyl-2-cyclohexenone

Cruciani,Margaretha

, p. 95 - 101 (2007/10/02)

The photochemical behaviour of the title compound, newly synthesized in four steps from 4,4-dimethylcyclohexanone, is compared to that of 4,4-dimethyl- and 4,4,6-trimethyl-2-cyclohexenone. All three enones undergo rearrangement to bicyclo[3.1.0]hexan-2-on

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 41172-02-5